We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
4 hedge funds and large institutions have $111K invested in Decoy Therapeutics in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more ownership
Funds ownership: 0% → 0% (+0%)
75% less funds holding
Funds holding: 16 → 4 (-12)
83% less capital invested
Capital invested by funds: $671K → $111K (-$560K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 12
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Holders
4
Holders Change
-12
Holders Change %
-75%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Two Sigma Advisers
New York
|
-$60K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$42.6K |
| 3 |
State Street
Boston,
Massachusetts
|
-$28K |
| 4 |
Renaissance Technologies
New York
|
-$24.8K |
| 5 |
Millennium Management
New York
|
-$23K |
